Comparison of prevalence, clinical evolution and vaccination rate against COVID 19 in a population of patients diagnosed with Dual Bipolar disorder and Non-dual bipolar disorder

Introduction Since the beginning of the pandemic, 4,745,519 cases, 396,878 hospitalizations and 82,884 deaths with COVID-19 have been reported in Spain. As of August 24, 2021, 76.4% of Andalusians over 12 years of age have the complete vaccination regimen. Objectives Main: to calculate the prevalenc...

Full description

Saved in:
Bibliographic Details
Published inEuropean psychiatry Vol. 65; no. S1; pp. S408 - S409
Main Authors Losilla Rodríguez, B., Palermo Zeballos, F., Ortiz Jiménez, M.
Format Journal Article
LanguageEnglish
Published Paris Cambridge University Press 01.06.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Introduction Since the beginning of the pandemic, 4,745,519 cases, 396,878 hospitalizations and 82,884 deaths with COVID-19 have been reported in Spain. As of August 24, 2021, 76.4% of Andalusians over 12 years of age have the complete vaccination regimen. Objectives Main: to calculate the prevalence of COVID 19 infection, clinical evolution, and vaccination rate in a population of patients diagnosed with dual bipolar disorder. Secondary: compare these data with those obtained inpatients diagnosed with non-dual bipolar disorder. Methods Retrospective descriptive study. The study population is made up of patients diagnosed with dual bipolar disorder and non-dual bipolar disorder (according to DSM 5 criteria). Infection, admission, death, and vaccination data were obtained from the patient’s medical history. Results Of the 7 patients diagnosed with dual bipolar disorder, the prevalence of COVID 19 infection, since the beginning of the pandemic is 0% and of the 21 patients diagnosed with non-dual bipolar disorder the prevalence is 9.51% (2/21). Of the patients with COVID 19 infection, none required hospital admission and no deaths occurred. The vaccination rate in the group of patients with dual bipolar disorder is 85,71% (6/7) and in the group of non-dual bipolar disorder is 61.91% (13/21), no finding statistically significant differences between both groups. Conclusions In our study the prevalence of COVID 19 infection inpatients diagnosed with dual bipolar disorder is 0% and the vaccination rate is 85.71%. While in patients with non-dual bipolar disorder the prevalence is 9.51%, there were no admissions, no deaths and the vaccination rate is 61.91%. Disclosure No significant relationships.
AbstractList Introduction Since the beginning of the pandemic, 4,745,519 cases, 396,878 hospitalizations and 82,884 deaths with COVID-19 have been reported in Spain. As of August 24, 2021, 76.4% of Andalusians over 12 years of age have the complete vaccination regimen. Objectives Main: to calculate the prevalence of COVID 19 infection, clinical evolution, and vaccination rate in a population of patients diagnosed with dual bipolar disorder. Secondary: compare these data with those obtained inpatients diagnosed with non-dual bipolar disorder. Methods Retrospective descriptive study. The study population is made up of patients diagnosed with dual bipolar disorder and non-dual bipolar disorder (according to DSM 5 criteria). Infection, admission, death, and vaccination data were obtained from the patient’s medical history. Results Of the 7 patients diagnosed with dual bipolar disorder, the prevalence of COVID 19 infection, since the beginning of the pandemic is 0% and of the 21 patients diagnosed with non-dual bipolar disorder the prevalence is 9.51% (2/21). Of the patients with COVID 19 infection, none required hospital admission and no deaths occurred. The vaccination rate in the group of patients with dual bipolar disorder is 85,71% (6/7) and in the group of non-dual bipolar disorder is 61.91% (13/21), no finding statistically significant differences between both groups. Conclusions In our study the prevalence of COVID 19 infection inpatients diagnosed with dual bipolar disorder is 0% and the vaccination rate is 85.71%. While in patients with non-dual bipolar disorder the prevalence is 9.51%, there were no admissions, no deaths and the vaccination rate is 61.91%. Disclosure No significant relationships.
IntroductionSince the beginning of the pandemic, 4,745,519 cases, 396,878 hospitalizations and 82,884 deaths with COVID-19 have been reported in Spain. As of August 24, 2021, 76.4% of Andalusians over 12 years of age have the complete vaccination regimen.ObjectivesMain: to calculate the prevalence of COVID 19 infection, clinical evolution, and vaccination rate in a population of patients diagnosed with dual bipolar disorder. Secondary: compare these data with those obtained inpatients diagnosed with non-dual bipolar disorder.MethodsRetrospective descriptive study. The study population is made up of patients diagnosed with dual bipolar disorder and non-dual bipolar disorder (according to DSM 5 criteria). Infection, admission, death, and vaccination data were obtained from the patient’s medical history.ResultsOf the 7 patients diagnosed with dual bipolar disorder, the prevalence of COVID 19 infection, since the beginning of the pandemic is 0% and of the 21 patients diagnosed with non-dual bipolar disorder the prevalence is 9.51% (2/21). Of the patients with COVID 19 infection, none required hospital admission and no deaths occurred. The vaccination rate in the group of patients with dual bipolar disorder is 85,71% (6/7) and in the group of non-dual bipolar disorder is 61.91% (13/21), no finding statistically significant differences between both groups.ConclusionsIn our study the prevalence of COVID 19 infection inpatients diagnosed with dual bipolar disorder is 0% and the vaccination rate is 85.71%. While in patients with non-dual bipolar disorder the prevalence is 9.51%, there were no admissions, no deaths and the vaccination rate is 61.91%.DisclosureNo significant relationships.
Introduction Since the beginning of the pandemic, 4,745,519 cases, 396,878 hospitalizations and 82,884 deaths with COVID-19 have been reported in Spain. As of August 24, 2021, 76.4% of Andalusians over 12 years of age have the complete vaccination regimen. Objectives Main: to calculate the prevalence of COVID 19 infection, clinical evolution, and vaccination rate in a population of patients diagnosed with dual bipolar disorder. Secondary: compare these data with those obtained inpatients diagnosed with non-dual bipolar disorder. Methods Retrospective descriptive study. The study population is made up of patients diagnosed with dual bipolar disorder and non-dual bipolar disorder (according to DSM 5 criteria). Infection, admission, death, and vaccination data were obtained from the patient’s medical history. Results Of the 7 patients diagnosed with dual bipolar disorder, the prevalence of COVID 19 infection, since the beginning of the pandemic is 0% and of the 21 patients diagnosed with non-dual bipolar disorder the prevalence is 9.51% (2/21). Of the patients with COVID 19 infection, none required hospital admission and no deaths occurred. The vaccination rate in the group of patients with dual bipolar disorder is 85,71% (6/7) and in the group of non-dual bipolar disorder is 61.91% (13/21), no finding statistically significant differences between both groups. Conclusions In our study the prevalence of COVID 19 infection inpatients diagnosed with dual bipolar disorder is 0% and the vaccination rate is 85.71%. While in patients with non-dual bipolar disorder the prevalence is 9.51%, there were no admissions, no deaths and the vaccination rate is 61.91%. Disclosure No significant relationships.
Author Losilla Rodríguez, B.
Ortiz Jiménez, M.
Palermo Zeballos, F.
AuthorAffiliation Hospital Universitario Virgen Macarena , Psychiatry, Sevilla , Spain
AuthorAffiliation_xml – name: Hospital Universitario Virgen Macarena , Psychiatry, Sevilla , Spain
Author_xml – sequence: 1
  givenname: B.
  surname: Losilla Rodríguez
  fullname: Losilla Rodríguez, B.
– sequence: 2
  givenname: F.
  surname: Palermo Zeballos
  fullname: Palermo Zeballos, F.
– sequence: 3
  givenname: M.
  surname: Ortiz Jiménez
  fullname: Ortiz Jiménez, M.
BookMark eNpdktGO1CAUholZE2dXX8ArEm_tLJRS6I2Jzuo6yca9UW_JKdBZmg5UaMfsY_mG0unGZL0Czv_nOxz4L9GFD94i9JaSLaVNed1v7RzH9LgtSVluKWHiBdpQIWTBuOQXaEOasioaxuQrdJlSTwgVhNQb9GcXjiNEl4LHocNjtCcYrNf2PdaD807DgO0pDPPksgO8wSfQ2nk4nyNMFsMBnE8T3t3_3N9g2mCXjXgM4zysroWbd9ZPCRsHBx-SNfi3mx7wzZz5n9wYBohZSyEaG89tvgVfmEVt_1Nfo5cdDMm-eVqv0I8vn7_vvhZ397f73ce7QpesFoVkvKnqVpqKdwyEIKJtdZ5ZdB2rjOatqGTFOguSUM0Yt5oIwWoqcq0x-aWu0H7lmgC9GqM7QnxUAZw6F0I8KIiT04NVloOmrTGCd7xqSpBNRapaWzAdaQnUmfVhZY1ze7RG56eIMDyDPle8e1CHcFINrwWVy2XePQFi-DXbNKk-zNHn-VUpiBT5N8smu8rVpWNIKdruXwdK1JIT1as1J2rJiVpywv4ChFy42A
ContentType Journal Article
Copyright The Author(s), 2022. Published by Cambridge University Press on behalf of the European Psychiatric Association. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2022 2022 The Author(s)
Copyright_xml – notice: The Author(s), 2022. Published by Cambridge University Press on behalf of the European Psychiatric Association. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2022 2022 The Author(s)
DBID AAYXX
CITATION
3V.
7XB
88G
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
COVID
DWQXO
FYUFA
GHDGH
GNUQQ
M2M
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
5PM
DOA
DOI 10.1192/j.eurpsy.2022.1037
DatabaseName CrossRef
ProQuest Central (Corporate)
ProQuest Central (purchase pre-March 2016)
Psychology Database (Alumni)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
AUTh Library subscriptions: ProQuest Central
ProQuest One Community College
Coronavirus Research Database
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Psychology Database
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
Publicly Available Content Database
ProQuest One Psychology
ProQuest Central Student
ProQuest Central Basic
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
Health Research Premium Collection
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest Central Korea
ProQuest One Academic
ProQuest Central (Alumni)
DatabaseTitleList
Publicly Available Content Database
CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: COVID
  name: Coronavirus Research Database
  url: https://proxy.k.utb.cz/login?url=https://search.proquest.com/coronavirus
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1778-3585
EndPage S409
ExternalDocumentID oai_doaj_org_article_e5ac1bdd75f5492a894046ceadf0b0a6
10_1192_j_eurpsy_2022_1037
GroupedDBID ---
--K
--M
.1-
.FO
.~1
09C
09E
0R~
0SF
1B1
1P~
1~.
1~5
29G
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8FI
8FJ
8P~
AABNK
AACTN
AAEDT
AAEDW
AAFWJ
AAIKJ
AAKOC
AALRI
AANRG
AAOAW
AAQXK
AASVR
AAXUO
AAYXX
ABBQC
ABBZL
ABFNM
ABIVO
ABJNI
ABMZM
ABUWG
ABVZP
ABXAU
ABXDB
ACDAQ
ACGFS
ACHQT
ACIUM
ACQPF
ACZWT
ADAZD
ADBBV
ADDNB
ADEZE
ADKIL
ADMUD
ADOVH
ADVJH
ADVLN
AEBAK
AEKER
AENCP
AENEX
AEVXI
AEYHU
AFCTW
AFKRA
AFPKN
AFRHN
AFTJW
AGABE
AGHFR
AGJUD
AGUBO
AGYEJ
AHIPN
AHRGI
AITUG
AJOXV
AJPFC
AJRQY
AJUYK
AKRWK
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
AQJOH
ASPBG
AVWKF
AZFZN
AZQEC
BENPR
BLXMC
BLZWO
CCPQU
CCQAD
CCUQV
CFBFF
CGQII
CITATION
CJCSC
CS3
CTKSN
DOHLZ
DU5
DWQXO
EBS
EGQIC
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYUFA
G-Q
GBLVA
GNUQQ
GROUPED_DOAJ
HVGLF
HZ~
IHE
IKXGN
IOO
IPYYG
J1W
LN9
M2M
M41
MO0
N9A
NCXOZ
NZEOI
O-L
O9-
OAUVE
OH0
OK1
OU-
OZT
P-8
P-9
P2P
PC.
PIMPY
PSYQQ
Q38
R2-
RCA
RIG
ROL
RPM
RPZ
SCC
SDF
SDG
SDP
SES
SEW
SSZ
T5K
UHS
UKHRP
UV1
WFFJZ
Z5R
~G-
3V.
7XB
8FK
COVID
PQEST
PQQKQ
PQUKI
PRINS
Q9U
5PM
ID FETCH-LOGICAL-c2367-835946b8d45f3a7707bbc7007ff34dc5b74843fea801c335ec07736173fe9d933
IEDL.DBID RPM
ISSN 0924-9338
IngestDate Fri Oct 04 13:04:52 EDT 2024
Tue Sep 17 21:30:58 EDT 2024
Thu Oct 10 15:56:54 EDT 2024
Thu Sep 26 16:15:08 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue S1
Language English
License This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2367-835946b8d45f3a7707bbc7007ff34dc5b74843fea801c335ec07736173fe9d933
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567183/
PQID 2708717029
PQPubID 4933639
ParticipantIDs doaj_primary_oai_doaj_org_article_e5ac1bdd75f5492a894046ceadf0b0a6
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9567183
proquest_journals_2708717029
crossref_primary_10_1192_j_eurpsy_2022_1037
PublicationCentury 2000
PublicationDate 20220601
PublicationDateYYYYMMDD 2022-06-01
PublicationDate_xml – month: 06
  year: 2022
  text: 20220601
  day: 01
PublicationDecade 2020
PublicationPlace Paris
PublicationPlace_xml – name: Paris
– name: Cambridge, UK
PublicationTitle European psychiatry
PublicationYear 2022
Publisher Cambridge University Press
Publisher_xml – name: Cambridge University Press
SSID ssj0017006
Score 2.3876553
Snippet Introduction Since the beginning of the pandemic, 4,745,519 cases, 396,878 hospitalizations and 82,884 deaths with COVID-19 have been reported in Spain. As of...
IntroductionSince the beginning of the pandemic, 4,745,519 cases, 396,878 hospitalizations and 82,884 deaths with COVID-19 have been reported in Spain. As of...
Introduction Since the beginning of the pandemic, 4,745,519 cases, 396,878 hospitalizations and 82,884 deaths with COVID-19 have been reported in Spain. As of...
SourceID doaj
pubmedcentral
proquest
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
StartPage S408
SubjectTerms Abstract
Bipolar disorder
covid 19
COVID-19 vaccines
dual disorder
E-Poster Viewing
Immunization
Infections
Pandemics
Prevalence
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gLojzEQlvNgRtETfxYr4_tlqogtVwo6i3yE5ZDNuq2lfhZ_YedsZNVw4UL1ziJHX8TzXzJzDeMfTAYA3ghbBWEQ4Ji7byyc7Rl7pJrrOTooql2-PxifnYpv16pq0etvignrMgDl407jMr6xoWgVSIxMbswEimdxw1ItattEdtu1Eimhv8Hus5dNWtkFxVS9sVYLmP44W9SVOw3f5Abcp5rzicuKSv3T8LNabLkI-9z-oI9H8JGOCrL3WVPYveSPT0ffoy_YvfLbT9BWCfor0nFm17aTzDWPkK8G8wMbBfgznq8NOMCJBcB9qddYawIy28_vpxAY2CFJ0K_bfCV71tUWDcQSoZeDEAfcuHkFu9_vOqJJ0MYBD3zNBfrrqJyL3B_jb5ml6efvy_PqqEbQ-VJ5a3CUM3IuVsEqZKwWtfaOY_7rFMSMnjlSJVUpGjR5yH6Kvpaa4EBEh4zAUF4w3a6dRffMvApGZk4xhY2Sme8iSK5KIxKUarQhBn7OALS9kV0o81kxXAkKwW-luBrCb4ZOybMtmeSYHY-gGbUDmbU_suMZmxvRLwd3uJNy3WNfFLX3MyYnljBZLLpSLf6lVW6kXii3xfv_sfq3rNn9LglRW2P7dxc38Z9DIZu3EG2-wfidA0-
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Coronavirus Research Database
  dbid: COVID
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZgKyEu5S0WCpoDN0ibjZ14fUJ0S1WQWi4U9Rb5WRakbLqPSvCv-IfMOM5CeuDANQ_nMZ_tb-yZbxh7pZADWM515rhBB0XrKtMVYrkwwUy0KHCKptzh07Pq5Fx8vCgv0oLbKoVV9mNiHKjdwtIa-UEhc-T2Mi_U2_Yqo6pRtLuaSmjcZjt8ip7OiO3MPn35cLTdR5B5rK6Zo5eRoes-7dNmVHHwjZQV29UP9BGLIuaeD6amqOA_oJ3DoMm_ZqHje6zu378LPvm-v1mbffvzhrTj_3_gfbabCCq86xD1gN3yzUN25zRtwT9iv2bbyoWwCNAuSS-choc30GdZgr9OgAbdOLjWFm-NCAASpgB9qefISiH-RJgomOOF0G5LicV2O73XFbguFtA7oCVjONpg-4fzljxycEk6ND7mbNFklFgG5sbZx-z8-P3n2UmW6j5klvTkMiSFSlRm6kQZuJYyl8ZYtKQMgQtnS0P6pzx4jbMr4qz0NpeSIxXDY8qhmZ-wUbNo_FMGNgQlQoEsRnthlFWeB-O5KoMXpZu4MXvdm7xuO3mPOrpFqkC3qANITQCpCSBjdkio2F5J0tzxwGJ5WaeeXvtS24lxTpaB1O_0VIlcVBZ7bMhNrqsx2-vtX6fxYlX_Mf6YyQHOBg8bnmnmX6MeOLq4yDD4s383_JzdpQ_pwtz22Gi93PgXSKjW5mXqNb8Bdfon6g
  priority: 102
  providerName: ProQuest
Title Comparison of prevalence, clinical evolution and vaccination rate against COVID 19 in a population of patients diagnosed with Dual Bipolar disorder and Non-dual bipolar disorder
URI https://www.proquest.com/docview/2708717029
https://pubmed.ncbi.nlm.nih.gov/PMC9567183
https://doaj.org/article/e5ac1bdd75f5492a894046ceadf0b0a6
Volume 65
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLW2ISFeEJ-iMKr7wBtkdW0nrh9pt2kgtUyIob1F_tyCWBq12yR-Fv-QayepCI88Rcp3cq7jc5x7jwl5p5ADWM515rhBgaJ1kekCY5mZYKZaMOyiY-3wclWcXYjPl_nlHsn7WpiUtG9NdVT_vDmqq-uUW9nc2EmfJzY5Xy6Q0-MnlU_2yb7kvJfo3a8DSdOEmhSFRYZqfdZXyig2-RHNFJvtL5SFjKVy80FvlEz7B0xzmCf5V8dz-oQ87hgjfGzv7CnZ8_Uz8nDZ_RN_Tn4vdlMJwjpAs4kG3rG9foC-7BH8fRdhoGsH99rioQkSiE4RoK90hTQRFl--fzqGqYIKd4RmN7dXOm9rwLoF1ybneQdxDBeO7_D886qJEhlc5-WZLrNa11ms9ALzz9YX5OL05NviLOsmYshsNHjLkKUpUZiZE3ngWkoqjbH4nmUIXDibm2hIyoPX2N0h8Lm3VEqO3AjXKYcgvCQH9br2rwjYEJQIDGmF9sIoqzwPxnOVBy9yN3Uj8r4HpGxav40y6RTFUKe08JURvjLCNyLziNluz-iVnVasN1dlFzGlz7WdGudkHqIdnZ4pQUVhsQkFaqguRuSwR7zsGvC2ZJKilJSUqRGRgygYXGy4BeM1GXR38fn6v498Qx7FZ2xT0g7Jwe3mzr9F8nNrxuTB_GR1_hWXKSbGaRBhnJrAH5uDDw4
link.rule.ids 230,315,733,786,790,870,891,2115,21416,27955,27956,33777,38549,43838,43928,53825,53827,74657,74767
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZgKwEX3hULBXzgBmmzthOvT4huqbbQXS4t6s3ysyxISdhHJfhX_EPGjrOQHjhwzcN5zGf7G3vmG4ReCeAAhlKVWarBQVGqzFQJWCba65FiBKbokDs8m5fTc_bhorhIC26rFFbZjYlxoLa1CWvkB4TnwO15TsTb5nsWqkaF3dVUQuMm2oGJlYwHaGfy6fPJ0XYfgeexumYOXkYGrvu4S5sR5OBrUFZsVj_ARyQk5p73pqao4N-jnf2gyb9moeN7SHbv3waffNvfrPW--XlN2vH_P_A-upsIKn7XIuoBuuGqh-jWLG3BP0K_JtvKhbj2uFkGvfAwPLzBXZYldlcJ0FhVFl8pA7dGBOAgTIHVpVoAK8XxJ-KRwAu4EDfbUmKx3VbvdYVtGwvoLA5LxvhoA-0fLprgkWObpEPjY-Z1lYXEMqyvnX2Mzo_fn02mWar7kJmgJ5cBKRSs1GPLCk8V5znX2oAlufeUWVPooH9KvVMwuwLOCmdyzilQMTgmLJh5Fw2qunJPEDbeC-YJsBjlmBZGOOq1o6LwjhV2ZIfodWdy2bTyHjK6RYKAW9QCRAaAyACQIToMqNheGaS544F6eSlTT5euUGakreWFD-p3aixYzkoDPdbnOlflEO119pdpvFjJP8YfIt7DWe9h_TPV4kvUAwcXFxgGffrvhl-i29Oz2ak8PZl_fIbuhI9qQ9720GC93LjnQK7W-kXqQb8BarAq0Q
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb9NAEF1BK1VcEJ8iUGAO3MCK4931Zk-IJI1aoKFCFPVm7WcJB9skbSV-Fv-Q2fU6YA5cbWet-M163_POvCHklUQOYChVmaUaBYpSZaZKjOVCez1RrMAlOtQOn67K43P2_oJfpPynbUqr7N-J8UVtGxO-kY8LkSO3F3khxz6lRZwtlm_bH1noIBV2WlM7jdtkX7CSoxDbnx2tzj7v9hREHjtt5qg4MpTx076ERhbj78Flsd3-RL1YFLEOfbBMRTf_AQUdJlD-tSIt75G7iUrCuw77--SWqx-Qg9O0Wf6Q_JrvegxC46HdBGfvMJHfQF8PCe4mhR6o2sKNMvjTiBUECwlQl2qN_BHmn76eLGAiYY0XQrtr-hXH7ZxZt2C7rD1nIXzchcU1jj9bt0E7g00mn_E2q6bOQgkY6H_OPiLny6Mv8-MsdWjITHB-y5C-SVbqqWXcUyVELrQ2-JyF95RZw3VwKqXeKVwHMSK4M7kQFEkTHpMWQXhM9uqmdk8IGO8l8wXyDeWYlkY66rWjknvHuJ3YEXndA1K1nRFHFQWMLFDAdPBVAb4qwDcis4DZ7spgoh0PNJvLKs3JynFlJtpawX3wqVNTyXJWGpxbPte5KkfksEe8SjN7W_2JwxERgygY3Gx4pl5_i87dKEaRC9Cn_x_4JTnA0K4-nqw-PCN3wn_qctMOyd7V5to9RxZ0pV-k8P4NHHYMIg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparison+of+prevalence%2C+clinical+evolution+and+vaccination+rate+against+COVID+19+in+a+population+of+patients+diagnosed+with+Dual+Bipolar+disorder+and+Non-dual+bipolar+disorder&rft.jtitle=European+psychiatry&rft.au=B.+Losilla+Rodr%C3%ADguez&rft.au=F.+Palermo+Zeballos&rft.au=M.+Ortiz+Jim%C3%A9nez&rft.date=2022-06-01&rft.pub=Cambridge+University+Press&rft.issn=0924-9338&rft.eissn=1778-3585&rft.volume=65&rft.spage=S408&rft.epage=S409&rft_id=info:doi/10.1192%2Fj.eurpsy.2022.1037&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_e5ac1bdd75f5492a894046ceadf0b0a6
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0924-9338&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0924-9338&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0924-9338&client=summon